首页> 外文期刊>Journal of Environmental Health Science and Engineering >Synthesis and study the controlled release of etronidazole from the new PEG/NaY and PEG/MCM-41 nanocomposites
【24h】

Synthesis and study the controlled release of etronidazole from the new PEG/NaY and PEG/MCM-41 nanocomposites

机译:从新型PEG / NaY和PEG / MCM-41纳米复合材料合成并研究依替硝唑的控制释放

获取原文
           

摘要

Recently, hybrid materials using poly ethylene glycol and porous nanocrystals have been developed for drug release. In this study, a series of poly ethylene glycol (PEG)/NaY zeolite and PEG/MCM-41 nanocomposites get synthesized. These materials are characterized using FT-IR spectroscopy, XRD, TGA and SEM. After loading the metronidazole onto these nanocomposites, the release of Metronidazole was studied in two kinds of release fluids simulating body fluid KH2PO4-Na2HPO4 buffer (pH = 7.4) and gastric fluid (HCl aqueous solution, pH = 1.5) while controlling the time, pH values, and temperature using UV–vis. Results showed that these nanocomposites have further release related to NaY, MCM-41 and the order of release in two pH solutions was PEG/NaY?>?PEG/MCM-41?>?NaY?>?MCM-41. The behavior of drug release in these nanocomposites is probably due to hydrogen bonding interactions between drug and the hydroxyl group on the composite framework.
机译:最近,已经开发了使用聚乙二醇和多孔纳米晶体的杂化材料用于药物释放。在这项研究中,合成了一系列聚乙二醇(PEG)/ NaY沸石和PEG / MCM-41纳米复合材料。这些材料使用FT-IR光谱,XRD,TGA和SEM进行表征。将甲硝唑加载到这些纳米复合材料上后,在模拟体液KH2PO4-Na2HPO4缓冲液(pH = 7.4)和胃液(HCl水溶液,pH = 1.5)的两种释放液中研究了甲硝唑的释放,同时控制了时间,pH值和使用UV-vis的温度。结果表明,这些纳米复合材料具有与NaY,MCM-41有关的进一步释放,并且在两种pH溶液中的释放顺序为PEG / NaY→> PEG / MCM-41 >> NaY→> MCM-41。这些纳米复合材料中药物释放的行为可能是由于药物与复合骨架上的羟基之间存在氢键相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号